Use App
Trending
News
Earnings
Newsletters
Advertise
All
DIA
0.48%
SPY
0.09%
QQQ
0.44%
Trending
SOL.X
2.35%
PUMP.X
35.98%
DOG.X
3.35%
UPDOG.X
15.62%
ZORA.X
12.47%
RUCKA.X
21.80%
DENGDENG.X
28.79%
JINGLE.X
0.22%
APU.X
1.24%
NYT
0.67%
SOL.X
2.35%
PUMP.X
35.98%
DOG.X
3.35%
UPDOG.X
15.62%
ZORA.X
12.47%
RUCKA.X
21.80%
DENGDENG.X
28.79%
JINGLE.X
0.22%
APU.X
1.24%
NYT
0.67%
home
Symbol
AZN
AZN
AstraZeneca PLC
18,751
Loading...
Loading...
Feed
News
Sentiment
Earnings
Fundamentals
Info
News
all
press releases
OLMA Stock Soars 47% in September So Far on Second PFE Deal
Olema Pharmaceuticals surges 47% in September after striking a second collaboration with Pfizer for its lead breast cancer product candidate, palazestrant.
Zacks
·
2d ago
Share to Feed
More News
Pfizer's Late-Stage Pipeline Fuels Long-Term Growth Prospects
Pfizer's late-stage pipeline, from oncology blockbusters to mRNA vaccines, positions it for long-term growth despite recent setbacks.
Zacks
·
2d ago
Is BDTX's Cash balance Enough to Successfully Develop Its NSCLC Drug?
Black Diamond sharpens focus on silevertinib after outlicensing BDTX-4933, cutting costs, and securing cash runway into late 2027.
Zacks
·
2d ago
The Zacks Analyst Blog Highlights Oracle, AstraZeneca, Shopify and Blue Ridge Bankshares
Oracle, AstraZeneca, Shopify, and Blue Ridge Bankshares show strong growth and strategic market opportunities.
Zacks
·
2d ago
Top Research Reports for Oracle, AstraZeneca & Shopify
Oracle's cloud boom, AstraZeneca's drug pipeline, and Shopify's AI tools headline fresh analyst reports on major stocks.
Zacks
·
3d ago
J&J Gains FDA Approval for Inlexzoh, Strengthens Pipeline Momentum
J&J secures FDA approval for Inlexzoh, which boosts its Innovative Medicine pipeline and reinforces long-term growth momentum.
Zacks
·
4d ago
LLY's Phase III Study on Jaypirca in Front-Line Leukemia Meets Goal
Lilly's Jaypirca shows a strong survival benefit over chemoimmunotherapy in treatment-naive CLL/SLL, boosting its potential in front-line use.
Zacks
·
5d ago
Will LLY's Oncology Portfolio Provide Key Diversification Benefits?
Eli Lilly's oncology portfolio, led by Verzenio and Jaypirca, is adding diversification to its cardiometabolic-driven growth story.
Zacks
·
5d ago
Why Astrazeneca (AZN) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks
·
5d ago
Why Astrazeneca (AZN) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
·
6d ago
Latest AZN News
View
Advertisement.
Remove ads.
Advertisement.
Remove ads.
Advertisement.
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile